Moderna in talks with FDA over post-marketing Covid shot data, with eyes on wider access

Moderna said it's working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after FDA leaders narrowed the label.

Raccontata daendpoints.news